For laboratory research use only · Not for human or veterinary use · 18+
Recovery research

Buy ARA-290 Peptide in Australia

Lyophilised powder, 10mg vial · Available to order, dispatched from Australia
$69.99

Buy ARA-290 in Australia from Macropus Peptides as a research-grade peptide in a sealed 10mg vial. Also known as cibinetide, it is an 11 amino acid peptide modelled on a small region of erythropoietin, designed to activate the body's tissue-protective innate repair receptor without stimulating red blood cell production. It has been studied in animal models of tissue injury and in clinical trials of small fibre neuropathy, and remains an investigational compound. Each vial holds lyophilised powder under a sealed closure, labelled with compound, strength, lot number and storage temperature, and every lot has its own certificate of analysis. The 10mg vial is priced and ready to order, with one lot covering a full in-vitro study. Order ARA-290 online with bacteriostatic water for reconstitution, and the parcel is dispatched from Australian stock to any address in the country. Sold to researchers aged 18 and over, strictly for in-vitro laboratory research and not for human or veterinary use.

1
Frequently bought together
BPC-157 5mg$74.99
KPV 10mg$99.99
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
CompoundARA-290
Amount10 mg
FormLyophilised powder
CategoryRecovery research
Storage-20 °C, protect from light
TestingHPLC purity 98% or higher and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label
Peptide calculator

ARA-290 10mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Vial content
10 mg
mg per mL5.00
mcg per mL5,000

Buy ARA-290 Australia: 10mg Research Peptide Vial

Macropus Peptides supplies ARA-290 to Australian laboratories as a research-grade peptide in a single 10mg vial. It belongs to a small group of peptides designed to separate the protective effects of a natural hormone from its other actions, and we list it in our recovery research range beside related tissue repair compounds. The vial is priced and ready to order, lot-released and dispatched from Australian stock, and every vial comes from the same controlled supply.

ARA-290 Australia: what cibinetide is

Also called cibinetide, this is a synthetic peptide of 11 amino acids. Its sequence copies a short stretch of helix B, one of the four helices that make up erythropoietin, the kidney hormone that drives red blood cell production. That region faces away from the part of erythropoietin that stimulates blood cell formation, which is why a peptide built from it keeps the hormone's tissue-protective signalling while leaving blood production untouched. The first residue is a pyroglutamate, and in the scientific literature the peptide is often called pyroglutamate helix B surface peptide. It was developed by a US biotechnology company and has been through clinical trials, but it is not approved as a medicine anywhere.

ARA-290 peptide: how it works in research

Erythropoietin acts through two different receptor arrangements. The classic one, a pair of erythropoietin receptors, drives red blood cell production. The second combines one erythropoietin receptor with the beta common receptor, also known as CD131, and is called the innate repair receptor because it switches on protective, anti-inflammatory signalling when tissue is stressed or injured. This peptide was designed to activate only that second receptor. In laboratory and animal studies that activity has been linked to reduced inflammatory signalling and preserved tissue after injury, and researchers use it to study nerve, kidney and heart injury models without the confounding effect of rising red cell counts.

ARA-290 research: what the studies show

Two PNAS papers frame the research. The first, in 2004, described how erythropoietin protects tissue through a heteroreceptor built from the erythropoietin receptor and the beta common subunit. The second, in 2008, showed that small peptides taken from the tertiary structure of erythropoietin could be tissue-protective without stimulating red cell production, the design principle behind this compound. Clinical work followed, with phase 2 trials in small fibre neuropathy linked to sarcoidosis and to type 2 diabetes. The sarcoidosis trial, published in Molecular Medicine in 2013, examined small nerve fibre symptoms and corneal nerve fibre density, and a 2014 paper in the same journal examined metabolic control and neuropathic symptoms in type 2 diabetes. Both trials were small and exploratory, and no phase 3 programme has been reported. The published studies are listed in our ARA-290 research studies library, each linked to PubMed.

ARA-290 vial specifications

SpecificationDetail
CompoundARA-290
Amount10 mg
FormLyophilised powder
CategoryRecovery research
Storage-20 °C, protect from light

Inside each vial is a freeze-dried white cake of peptide; the label records what it is, how much, which lot and how cold to keep it. The lot number ties the vial to its batch certificate of analysis, issued on request. Keep sealed vials frozen at -20 °C and away from light, and once the powder has been dissolved, keep the dissolved peptide chilled and out of the freezer.

ARA-290 price in Australia and cost per mg

StrengthPricePrice per mg
ARA-290 10mg$69.99$7.00 per mg

One listed Australian dollar price covers the 10mg vial, ready for checkout now; a tenth of it is what each milligram costs. It is one of the lower-priced vials in our recovery range, and because a single vial usually covers a whole study, most laboratories order two or more at once to keep repeat experiments on the same lot number.

ARA-290 10mg: one vial for a full study

The 10mg vial is the only size we sell, and it covers most in-vitro studies from one lot. Use 2 mL of bacteriostatic water for a working stock of 5 mg in each millilitre, or 5 mL if your assay runs at the weaker 2 mg per mL for protocols that work at lower concentrations. Because peptides of this size can be sensitive to handling, we recommend dividing the stock into single-use portions on the day it is mixed.

Best place to buy ARA-290 Australia

  • Sold online at macropuspeptides.com, priced at $69.99
  • Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
  • A certificate of analysis for every lot, matched to the lot number printed on the label
  • Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
  • Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
  • Payment by PayID or bank transfer, with your order ID as the reference

How to get ARA-290 online: ordering in five steps

  • Choose the 10mg vial
  • Enter how many vials the study needs and add them
  • Add bacteriostatic water to the order if you need a diluent
  • Pay and confirm that the order is adult laboratory use
  • Record the lot number when the parcel arrives and request its certificate

ARA-290 reconstitution calculator: bac water for the 10mg vial

The concentration calculator in each listing converts any diluent volume into mg and mcg per mL for the 10mg vial. In figures: 1 mL makes 10 mg per mL, 2 mL makes 5, 4 mL makes 2.5, and 5 mL makes 2, which equals 200 mcg in every 0.1 mL. Most laboratories use bacteriostatic water, added slowly down the inside of the vial and swirled gently rather than shaken. A solution that turns cloudy usually points to agitation, too little diluent or a temperature shock from adding cold liquid to a warm vial; let the vial warm up on the bench first, and throw out anything with specks in it. The remaining diluents sit under lab supplies and kits.

Is ARA-290 available in Australia

Australian laboratories can order it as research material, the sole form we sell. Nothing containing it appears on the ARTG, which rules out supply for human or veterinary use. Scheduling decisions rest with the TGA and may shift, so check your organisation's obligations under the Poisons Standard first.

ARA-290 for sale Australia wide: sent from Australian stock

Parcels leave Australian stock for Sydney, Brisbane, Perth, Hobart, Canberra and country towns nationwide, with no international leg. Researchers working on tissue protection and inflammation often compare this peptide with BPC-157, which is studied in tendon and gut repair models, and with KPV, a short anti-inflammatory tripeptide. Thymosin Alpha-1 and the rest of the recovery research range are listed alongside.

References

  1. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proceedings of the National Academy of Sciences of the USA. 2008.
  2. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proceedings of the National Academy of Sciences of the USA. 2004.
  3. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Molecular Medicine. 2013.
  4. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Molecular Medicine. 2014.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Research guides on ARA-290 10mg

Questions about ARA-290 10mg

Chat on WhatsApp
ARA-290 10mg$69.99